TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer.

Noura J Choudhury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.